Pulse Biosciences (PLSE) Invested Capital (2020 - 2025)
Historic Invested Capital for Pulse Biosciences (PLSE) over the last 6 years, with Q3 2025 value amounting to $92.7 million.
- Pulse Biosciences' Invested Capital rose 1713.99% to $92.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $92.7 million, marking a year-over-year increase of 1713.99%. This contributed to the annual value of $114.9 million for FY2024, which is 15893.15% up from last year.
- As of Q3 2025, Pulse Biosciences' Invested Capital stood at $92.7 million, which was up 1713.99% from $104.5 million recorded in Q2 2025.
- Pulse Biosciences' 5-year Invested Capital high stood at $118.5 million for Q1 2025, and its period low was -$10.7 million during Q1 2023.
- In the last 5 years, Pulse Biosciences' Invested Capital had a median value of $44.4 million in 2021 and averaged $49.4 million.
- The largest annual percentage gain for Pulse Biosciences' Invested Capital in the last 5 years was 207330.96% (2023), contrasted with its biggest fall of 15129.83% (2023).
- Pulse Biosciences' Invested Capital (Quarter) stood at $44.4 million in 2021, then crashed by 105.07% to -$2.2 million in 2022, then surged by 2073.31% to $44.4 million in 2023, then soared by 158.93% to $114.9 million in 2024, then dropped by 19.3% to $92.7 million in 2025.
- Its last three reported values are $92.7 million in Q3 2025, $104.5 million for Q2 2025, and $118.5 million during Q1 2025.